July 2021 Simoa® Publications: Alzheimer’s Disease
Plasma neurofilament light chain levels and cognitive testing as predictors of fast progression in Alzheimer’s disease
Santangelo R, et al.
European journal of neurology. 2021
Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease
Xiao Z, et al.
Alzheimers Res Ther. 2021;13:132
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
Bejanin A, et al.
JAMA Neurol. 2021
Effects of various pre-analytical conditions on blood-based biomarkers of Alzheimer’s disease
Ladang A, et al.
Clin Chem Lab Med. 2021
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy
Grothe MJ, et al.
Neurology. 2021
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
Ossenkoppele R, et al.
EMBO molecular medicine. 2021:e14398
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
Pereira JB, et al.
Brain : a journal of neurology. 2021
Characterizing plasma NfL in a community-dwelling multi-ethnic cohort: Results from the HABLE study
O’Bryant S, et al.
Alzheimer’s & dementia : the journal of the Alzheimer’s Association. 2021
A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation
Prins S, et al.
Alzheimers Res Ther. 2021;13:132
Blood biomarkers for the diagnosis of amnestic mild cognitive impairment and Alzheimer’s disease: A systematic review and meta-analysis
Qu Y, et al.
Neuroscience and biobehavioral reviews. 2021;128:479-486
Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP in individuals at risk of Alzheimer’s disease
Lemercier P, et al.
Neurobiology of Aging. 2021
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
Mielke MM, et al.
JAMA Neurology. 2021
July 2021 Simoa® Publications in Other Therapeutic Areas
